Acadian Asset Management’s Puma Biotechnology PBYI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$6.89M Hold
2,008,146
0.01% 506
2025
Q1
$5.94M Buy
2,008,146
+36,018
+2% +$107K 0.02% 455
2024
Q4
$6.01M Buy
1,972,128
+3,129
+0.2% +$9.54K 0.02% 468
2024
Q3
$5.02M Buy
1,968,999
+17,791
+0.9% +$45.3K 0.02% 500
2024
Q2
$6.36M Sell
1,951,208
-5,305
-0.3% -$17.3K 0.02% 443
2024
Q1
$10.4M Buy
1,956,513
+39,239
+2% +$208K 0.04% 291
2023
Q4
$8.3M Buy
1,917,274
+59,274
+3% +$257K 0.03% 330
2023
Q3
$4.88M Sell
1,858,000
-16,123
-0.9% -$42.4K 0.02% 443
2023
Q2
$6.61M Sell
1,874,123
-736
-0% -$2.6K 0.03% 385
2023
Q1
$5.79M Buy
1,874,859
+61,819
+3% +$191K 0.03% 420
2022
Q4
$7.67M Sell
1,813,040
-25,902
-1% -$110K 0.04% 332
2022
Q3
$4.35M Buy
1,838,942
+30,114
+2% +$71.3K 0.02% 437
2022
Q2
$5.15M Buy
1,808,828
+116,929
+7% +$333K 0.03% 407
2022
Q1
$4.87M Sell
1,691,899
-54,382
-3% -$157K 0.02% 472
2021
Q4
$5.31M Buy
1,746,281
+446,734
+34% +$1.36M 0.02% 442
2021
Q3
$9.11M Buy
1,299,547
+72,068
+6% +$505K 0.03% 331
2021
Q2
$11.3M Buy
1,227,479
+12,002
+1% +$110K 0.04% 305
2021
Q1
$11.8M Buy
1,215,477
+91,945
+8% +$894K 0.05% 304
2020
Q4
$11.5M Sell
1,123,532
-223,085
-17% -$2.29M 0.04% 311
2020
Q3
$13.6M Buy
1,346,617
+79,686
+6% +$804K 0.06% 264
2020
Q2
$13.2M Buy
1,266,931
+391,666
+45% +$4.08M 0.06% 280
2020
Q1
$7.39M Buy
875,265
+36,143
+4% +$305K 0.04% 312
2019
Q4
$7.34M Buy
839,122
+456,921
+120% +$4M 0.03% 367
2019
Q3
$4.11M Buy
382,201
+127,487
+50% +$1.37M 0.02% 505
2019
Q2
$3.24M Buy
254,714
+250,130
+5,457% +$3.18M 0.02% 482
2019
Q1
$178K Buy
+4,584
New +$178K ﹤0.01% 1383